<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04297631</url>
  </required_header>
  <id_info>
    <org_study_id>201911147</org_study_id>
    <nct_id>NCT04297631</nct_id>
  </id_info>
  <brief_title>Intraarticular Antibiotic in TKA</brief_title>
  <official_title>Prospective Study Investigating Antibiotic Elution From Free Intra-articular Vancomycin and Tobramycin After Cementless Total Knee Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine the intra-articular concentration of vancomycin and
      tobramycin after administration of vancomycin and tobramycin powder in primary cementless
      total knee arthroplasty and determine the serum concentrations of these antibiotics
      postoperatively.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be identified by medical record review to make sure they meet inclusion and
      exclusion criteria. Patients that qualify and sign consent will have tobramycin and
      vancomycin antibiotic powder placed into the knee during surgery. Postoperative drain fluid
      from the knee will be collected.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">February 14, 2020</start_date>
  <completion_date type="Anticipated">December 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Concentration of antibiotics in cementless knees post op</measure>
    <time_frame>24 hours</time_frame>
    <description>1. Determine the intra-articular concentration of vancomycin and tobramycin after administration of vancomycin and tobramycin powder in primary cementless total knee arthroplasty.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>serum concentrations</measure>
    <time_frame>24 hours</time_frame>
    <description>2. Determine the serum concentrations of these antibiotics postoperatively</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Antibotics in Cementless Knees</condition>
  <arm_group>
    <arm_group_label>Vancomycin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All patients getting vancomycin to see concentration after 24hrs in knee drain and serum levels.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tobramycin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All patients getting Tobramycin to see conceration after 24hrs in knee drain and serum levels.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tobramycin Powder</intervention_name>
    <description>Everyone gets tobramycin powder.</description>
    <arm_group_label>Tobramycin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Vancomyscin</intervention_name>
    <description>Everyone gets the vancomyscin powder.</description>
    <arm_group_label>Vancomycin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age over 18

          2. Total knee arthroplasty for primary osteoarthritis. Primary diagnosis of knee
             osteoarthritis

        Exclusion Criteria:

          1. Diminished mental capacity

          2. Vancomycin allergy

          3. Tobramycin allergy

          4. Chronic kidney disease stage III and stage IV
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>March 3, 2020</study_first_submitted>
  <study_first_submitted_qc>March 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 5, 2020</study_first_posted>
  <last_update_submitted>July 27, 2020</last_update_submitted>
  <last_update_submitted_qc>July 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tobramycin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

